Tag: cost-effectiveness

A model-based economic evaluation of Egypt's national breast cancer screening program estimates greater health outcomes at lower societal cost than ...

A retrospective analysis of 871 hospitalized COVID-19 patients at an Indonesian hospital found favipiravir was cheaper and showed a slightly ...

An evaluation of Ukraine's TESTporuch digital health initiative reports a 3.15 percent proxy conversion rate to HIV care services and ...

An economic evaluation of the Go Healthy randomized trial found a 16-week community-supported agriculture intervention for American Indians cost about ...

A modeling study finds risk-based LDCT screening thresholds in Singapore could improve efficiency and health gains compared with conventional age ...

A systematic review of 20 studies finds that yoga, cognitive behavioral therapy, self-management support and other non-drug treatments for low ...

A systematic review of 20 studies finds that most guideline-recommended non-drug, non-surgical treatments for low back pain are cost-effective compared ...

A pharmacoeconomic analysis using Asian cohort data from the INAVO120 trial finds that inavolisib plus palbociclib/fulvestrant is not cost-effective nationally ...

A cost-effectiveness model based on the HARMONi-6 trial finds that ivonescimab plus chemotherapy is unlikely to be cost-effective for advanced ...

A decision-tree and Markov model estimated that app-based specialist teleconsultation for oral lesions could save SUS patients money while producing ...

Researchers built a microsimulation model from biomarker-confirmed Alzheimer's disease patients showing that a 30% slowing of cognitive decline extends time ...

A new economic evaluation published in BMC Health Services Research concludes that ivonescimab plus chemotherapy, an emerging first-line option for ...

A model-based economic evaluation from PGIMER Chandigarh finds that adding cetuximab to radiotherapy or platinum-based chemotherapy for head and neck ...

A modelling study of 165 health zones in the Democratic Republic of Congo finds that elimination of Gambiense human African ...

A US modeling study estimates that second-line lisocabtagene maraleucel yields slightly more quality-adjusted life-years at a lower total cost than ...

The ADVANCE protocol plans a 237-participant trial in Italy comparing two WHO psychological programs with a psychological placebo while assessing ...

A systematic review of 22 healthcare implementation studies found that 16 measured costs without linking them to health or effectiveness ...

A 40-year NHS cost-effectiveness model estimated that CYP2C19-guided dual antiplatelet therapy after PCI was likely cost-effective for STEMI and UA/NSTEMI ...

A model using real-world clinical data found that biannual liver cancer surveillance could be cost-effective at an annual risk as ...

A 20-year Markov modeling study from Bulgaria finds that adding treatment-free remission phases to chronic myeloid leukemia care lowers costs ...